ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Address : 180 Varick Street, New York, United States
Phone Number : +1 317-276-2000
Industries : Research, Biotechnology
Website : imclone.com
Company Description
ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Systems became a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY).
Specialities
- Monoclonal Antibodies & Biopharmaceutical Company
- Life Sciences
- Biotechnology Research
- Biotechnology
- Research
Financial
Employees Total : 390
Revenue (Yearly) : 300M
Public Company : Yes
Trade Symbol : IMCL
Market Cap : 300M
Miscellaneous
Founded in : 1984
Linkedin : imclone-systems-a-wholly-owned-subsidiary-of-eli-lilly-and-company
Angellist : angel.co/imclone-systems
Domain Name Services : UltraDns
Email Providers : Outlook
Tech : Microsoft Office 365
Last Updated : 2023-12-19
Employees
- Edward Craven ( Chief Utility Engineer )
- Jennifer Mahoney ( Sr. Computer Validation Specialist )
- Angel Arrubla ( Lead Technician )
- Marilyn Brandt ( Associate Director, Regulatory Affairs CMC )
- Maria Petrillo ( Operator III )
- Mark Rutstein ( Associate Vice President )
- Margaret Wlodarska ( QC Scientist )
- Mark Clark ( Sr. Engineer - Plant Engineering )
- Maureen Okwuonu ( Operator II )
- Katarzyna Case ( Scientist, Cell Culture Process Development )
- John Watkins ( Systems Analyst III )
Alumni
- Alice Matathia ( Scientist )
- Amy Desanto ( Research Scientist )
- Albina Taigounov ( Senior Manager, Regulatory CMC )
- Bill Strong ( Associate Director, Key Accounts - Oncology )
- Akshat Parekh ( Intern - Formulation Development Biophysical Characterization )
- Andrew Moore ( Summer Intern )
- Arun Gaur ( Scientist III/Quality Control Supervisor )
Competitors
 | MacroGenics, Inc. research 151.9B yearly revenue |
 | Retrophin biotechnology 198.0M yearly revenue |
 | Human Genome Sciences biotechnology 300M yearly revenue |
 | Receptos, a wholly-owned subsidiary of Celgene research 5.9M yearly revenue |
 | Neurocrine Biosciences research 1.8B yearly revenue |
 | ADOCIA research 2.4M yearly revenue |
You Might Be Interested With:
 | IOM - UN Migration Geneva, Switzerland International Affairs |
 | Wattpad Toronto, Ontario, Canada |
 | Nationalt Videnscenter for Hovedpine Glostrup, Capital Region of Denmark, Denmark Hospital & Health Care |
 | Skanska Stockholm, Stockholm County, Sweden Construction |
 | OC405 Partners Santa Ana, California, United States Construction |
 | JM Recycling Los Angeles, California, United States Consumer Services |